# Iovance Biotherapeutics, Inc.: Form SC 13D/A, filed Mar 19, 2024

- Company: [Iovance Biotherapeutics, Inc.](/companies/iova.md) (CIK 1425205)
- Form: SC 13D/A
- Filed: 2024-03-19
- Accepted by EDGAR: Mar 19, 2024, 17:19 ET
- Period: not reported
- Accession: 0001104659-24-036221
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1425205/000110465924036221/tm249236d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1425205/000110465924036221/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1425205/000110465924036221/tm249236d1_sc13da.htm

Filed Mar 19, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-036221. Last ingested by Listed: Nov 11, 2026, 02:51 ET. No prices; not investment advice.